ClinicalTrials.gg
RecruitingNCT04717388AudiCogUpdated Dec 12, 2024

Pathophysiology, Psycho-emotional and Cognitive Functioning Associated With Tinnitus

An interventional study of acoustics tests, Questionaries, and MRI in Tinnitus and Epilepsy, Temporal Lobe, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-12.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Jun 2021; still recruiting 5 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 29 studies in Tinnitus with a site in France — 11 open to participants now, 11 under way, none of them phase 3. Tinnitus · France.

Planned enrollment
3rd of 24
300 · median 71
Started
2021
with 1 other
No phase
19 of 29
10 open now
Primary completion
2027-10
later than 6 of 10 live
Registered
14th of 29
by date
Lead sponsor
3 of 29
Assistance Publique - Hôpitaux de Paris

Among the 29 studies in Tinnitus with a site in France, this one is the 3rd largest by planned enrollment of the 24 interventional ones that give a count, is one of 2 that started in 2021, is one of 19 with no phase, reaches primary completion later than 6 of the 10 other live ones, and was the 14th registered.

Tinnitus

446 studies on the registry are indexed under Tinnitus; 98 are open to participants now.

Browse Tinnitus studies →

Open to participants now

11 of the 29 studies in Tinnitus with a site in France are open now. Recruiting first, the newest first:

5 more — sign in →

All 11 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 49 Tinnitus studies recruiting now, 21 (43%) set no upper age limit and 18 (37%) stop at 75 or younger; 4 take children under 18; 10 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies in Tinnitus with a site in France, or all of them as a file.
02

Study summary

the investigators have recently shown that patients with drug-resistant temporal lobe epilepsy who have undergone brain surgery targeting the medial temporal lobe structures were more likely to develop tinnitus postoperatively. This discovery of a vulnerability to tinnitus associated with medial temporal lobe surgery to eliminate drug-refractory epileptic seizures provides a new clinical model of tinnitus, targeting temporal lobe regions as generators or mediators of this hearing disorder. The objective of this project is to study the impact of tinnitus on the cognitive, emotional, psychoacoustic and cerebral functioning associated with this hearing disorder, and to clarify the pathophysiology of tinnitus by comparing different groups of individuals with tinnitus (surgical epileptic patients or non-surgical ORL patients) to matched tinnitus-free groups (surgical tinnitus-free cases and healthy controls volunteer).

Read the detailed description

Tinnitus (known as "ringing in the ears") is a disabling medical condition. Its psychosocial impact is substantial, including anxiety, depression, stress, irritability, concentration and sleep disorder leading to detrimental effects on communication, education, professional fulfillment, mental health and quality of life. The cerebral bases of tinnitus and its consequence on human hearing health have received a lot of attention in the scientific literature. Yet, the relationship between the neurobiological dysfunction, psychological processes and clinical semiology of tinnitus remains poorly understood. Considering the current gaps in knowledge, there is a real need for clinical investigations into tinnitus-related brain changes and rigorous hearing, psycho-emotional, and cognitive assessments. the investigators recent discovery of a vulnerability to tinnitus associated with medial temporal lobe surgery (to treat refractory epilepsy) provides a new clinical model, which targets the temporal lobe regions as a tinnitus generator or mediator of its severity. The goal of this collaborative interdisciplinary study is to advance knowledge about the pathophysiology of tinnitus, as well as the socio-emotional, cognitive and psychoacoustic aspects associated to this hearing disorder. the investigators will first, characterize the subjective and self-reported hearing disorders with objective psychoacoustic, cognitive and affective measures in tinnitus sufferers and second, clarify the cerebral network underlying tinnitus and elucidate the role temporal lobe regions in the brain networks at play in surgical and non-surgical tinnitus. To this end, individuals with and without tinnitus, who had undergone or not a surgery will be compared in a 2 by 2 design. Investigating different patient cohorts with tinnitus who are well matched to both, healthy control populations and vulnerable clinical populations, without tinnitus is a valuable contribution of our proposal. Moreover, the psychological and hearing profiles of people with tinnitus will be examined in relation with their brain morphology and connectivity profiles.The project builds upon the internationally recognized leadership of the PI and her collaborators in the fields of auditory cognition and its neurobiological bases using neuropsychological, psychoacoustic, and neuroimaging methods in clinical populations. The members of the investigators consortium have all the necessary and unique expertise to carry out this innovative and interdisciplinary project.

03

Conditions studied

  • Tinnitus
  • Epilepsy, Temporal Lobe

Keywords

  • Tinnitus
  • Epilepsy
  • Cognitive Functioning
  • Brain connectivity
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Common Criteria for Inclusion :

  • Age ≥ 18 years old
  • Good written and oral comprehension of the French language
  • Person affiliated to a Social Security scheme
  • signed by the participant
  • Normal or corrected vision
  • Absence of known pre-existing neurological and/or degenerative disorders

Group Specific Inclusion Criteria :

Tinnitus+ Group - Suffering from subjective uni- or bilateral tinnitus, chronic (>3 months) and stable (no period of remission).

Chir+ Group

  • Surgically treated for drug-resistant epilepsy of the temporal lobe (including the amygdala).

Group Tinnitus-

  • Not suffering from tinnitus Group Chir-
  • Non epileptic
  • Not having undergone surgical treatment of the temporal lobe (including the tonsil)

Exclusion criteria:

  • Presence of severe or profound deafness, uni or bilateral.
  • Under legal protection (guardianship, curators, etc.)

Additional criteria for patients completing visit V2 :

  • MRI or claustrophobic
  • Pregnant or breastfeeding woman.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    impact of tinnitus on executive cognitive functioning

    Other: acoustics tests, Questionaries,

  • Experimental
    impact of tinnitus on reorganization of functional/ structural brain connectivity maps

    Other: acoustics tests, Questionaries, · Radiation: MRI

Interventions

  • Otheracoustics tests, Questionaries,

    acoustics tests at V1 Questionaries at V1 * cognitive * emotional * auditory

  • RadiationMRI

    Anatomical and functional MRI at V2

06

What researchers measure

Primary outcomes

  1. Evaluation of the impact of tinnitus on executive cognitive functioning

    Measurement of executive control using a stroop test in people with and without chronic tinnitus.

    Time frame: at the second visit, maximum 6 month after first visit.

Secondary outcomes

  1. Emotional functioning (anxiety and depression)

    Measures of Anxiety and Depression using: Hospital Anxiety and Depression Scale (HADS) : 14 rated items from 0 to 3. Seven questions are related to anxiety and seven to the depressive dimension, allowing for thus obtaining two scores (maximum score of each score = 21).

    Time frame: at the second visit, maximum 6 month after first visit.

  2. psycho-acoustic functioning

    Measurements of auditory functioning through hearing assessment (audiometry) : - Self-assessment questionnaires for hearing loss: The self-assessment of hearing loss is based on a yes/no question: "Do you feel that you have a hearing loss or hearing loss?

    Time frame: at the second visit, maximum 6 month after first visit.

  3. psycho-acoustic functioning

    Measurements of auditory functioning through hearing assessment (audiometry) : - The noise hypersensitivity questionnaire( Khalfa, 2002) provides a score ranging from 0 (no hypersensitivity) to 42 (very strong hypersensitivity).

    Time frame: at the second visit, maximum 6 month after first visit.

  4. psycho-acoustic functioning

    Measurements of auditory functioning through hearing assessment (audiometry) : - The severity of tinnitus is measured by the Tinnitus Handicap Inventory (THI) questionnaire. Scores range from 0 (mild discomfort) to 100 (catastrophic impact).

    Time frame: at the second visit, maximum 6 month after first visit.

  5. psycho-acoustic functioning

    Measurements of auditory functioning through hearing assessment (audiometry) : - Hearing threshold measurement (pure tones from 125-16000Hz)

    Time frame: at the second visit, maximum 6 month after first visit.

  6. psycho-acoustic functioning

    Measurements of auditory functioning through hearing assessment (audiometry) : - Discomfort threshold measurement (with 1kHz sound)

    Time frame: at the second visit, maximum 6 month after first visit.

  7. psycho-acoustic functioning

    Measurements of auditory functioning through hearing assessment (audiometry) : Evaluation of transient otoacoustic emissions (TEOAE) or by distortion product (DPOAE)

    Time frame: at the second visit, maximum 6 month after first visit.

  8. cognitive functioning, other than executive functioning (attention, memory)

    Measures of cognitive functioning : - the Attentional Network Test (ANT) visual attention test. ANT gives three attention scores based on reaction times. These scores represent the ability to direct attention, to be alert to surrounding stimuli and the executive part of attention.

    Time frame: at the second visit, maximum 6 month after first visit.

  9. cognitive functioning, other than executive functioning (attention, memory)

    Measures of cognitive functioning : - Mental Flexibility Score (Trail Making Test): The scores of the TMT (Trail Making Test) are expressed in time of completion. The faster the time to completion, the better the performance. So we have 2 scores, one for board A of the test: TMT-A and the other for board B of the test: TMT-B.

    Time frame: at the second visit, maximum 6 month after first visit.

  10. cognitive functioning, other than executive functioning (attention, memory)

    Measures of cognitive functioning : Measures of cognitive functioning :- Short-term memory score (auditive-verbal span). Score between 1 and 10, where 10 represents the best short-term memory score

    Time frame: at the second visit, maximum 6 month after first visit.

  11. cognitive functioning, other than executive functioning (attention, memory)

    Measures of cognitive functioning : Measures of cognitive functioning :- Working memory score (Brown-Peterson). The Brown Peterson gives a memorization score ranging from 0 to 100, where 100% is the best score.

    Time frame: at the second visit, maximum 6 month after first visit.

  12. cognitive functioning, other than executive functioning (attention, memory)

    Measures of cognitive functioning : - Episodic memory score in auditory modality. The episodic memory test in auditory mode gives a memorization score ranging from 0 to 100, where 100% represents a perfect memorization score.

    Time frame: at the second visit, maximum 6 month after first visit.

  13. the reorganization of functional and structural brain connectivity maps

    Functional and structural brain connectivity measurements using brain imaging (fMRI, diffusion and resting MRI) : - Volumetric measurement (in particular of the amygdala and the parahippocampal cortex)

    Time frame: at the third visit, maximum 18 month after the first visit

  14. the reorganization of functional and structural brain connectivity maps

    Functional and structural brain connectivity measurements using brain imaging (fMRI, diffusion and resting MRI) : - Measurement of anatomical connections between regions of interest (i.e. amygdala, auditory cortex, attention network including the precuneus and prefrontal cortex) from diffusion tensor imaging (TDI): fractional anisotropy (FA), mean diffusivity (MD), radial (RD) and axial (AD).

    Time frame: at the third visit, maximum 18 month after the first visit

  15. the reorganization of functional and structural brain connectivity maps

    Functional and structural brain connectivity measurements using brain imaging (fMRI, diffusion and resting MRI) : - Measurement of structural connectivity from fMRI at rest between predefined regions of interest and over new regions of interest defined during an attentional activation task

    Time frame: at the third visit, maximum 18 month after the first visit

  16. the reorganization of functional and structural brain connectivity maps

    Functional and structural brain connectivity measurements using brain imaging (fMRI, diffusion and resting MRI) : - Measurement of the amplitude of the synchrony of slow fluctuations and statistical dependencies in functional connectivity by comparing data from people with and without chronic tinnitus.

    Time frame: at the third visit, maximum 18 month after the first visit

  17. Emotional functioning (stress)

    Measures of stress using Perceived Stress Scale (PSS-4): Lowest score: 0, Highest score: 16, Higher scores are correlated to more stress.

    Time frame: at the second visit, maximum 6 month after first visit.

  18. Emotional functioning (Auditory recognition of emotions)

    Measures of Auditory recognition of emotions using hearing tests with recordings

    Time frame: at the second visit, maximum 6 month after first visit.

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2021 (actual). Primary completion is estimated for Oct 2027, 76 months after the start.

Of 134 non-industry interventional studies with no phase under Tinnitus, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 38. This study's planned 76 months is above that.

Counting every sponsor, half of 153 studies reached it within 17 months; a quarter within 10 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 15, 2020
First posted
Jan 22, 2021
StartActual
Jun 15, 2021
Primary completionEst.
Oct 15, 2027
CompletionEst.
Apr 15, 2029
Last update
Dec 12, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04717388
Responsible party
Sponsor
First posted
Jan 22, 2021
Start date
Jun 15, 2021
Primary completion
Oct 15, 2027 (estimated)
Completion
Apr 15, 2029 (estimated)
Last update
Dec 12, 2024

Study contacts

Sophie DUPONT, MD, Ph.D
Contact
sophie.dupont@aphp.fr
01 42 16 03 01
Séverine Samson, Ph.D
Contact
severine.samson@univ-lille.fr
03 20 41 64 43
Sophie Dupont, MD, Ph.D
study director · AP-HP Hopital Pitié-Salpêtrière

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion